Tapewire

Nasdaq · USD

NRC

NRC HEALTH

Export transactions ↓
Tapewire entity
5534
SEC CIK
0000070487
Parsed reports
357

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 23, 2026 Filed Jun 25, 2026 20:42 UTC GrantCommon Stock 7,697 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000188 · form4.xml · nonDerivative · entry 1

Bhandari Parul · CIK 0001861355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,697

F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:45 UTC GrantCommon Stock 7,697 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000189 · form4.xml · nonDerivative · entry 1

Berwick Donald M · CIK 0001656313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,697

F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:41 UTC GrantCommon Stock 7,697 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000187 · form4.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,697

F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:39 UTC GrantCommon Stock 7,697 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000186 · form4.xml · nonDerivative · entry 1

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,363

F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 20:37 UTC GrantCommon Stock 7,697 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000185 · form4.xml · nonDerivative · entry 1

Wheeler Penny Ann · CIK 0001856610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,697

F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:39 UTC
Rau Jason RussellExecutive Vice President
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000076 · form4.xml · nonDerivative · entry 1

Rau Jason Russell · CIK 0002095739 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · kind: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares vest in three equal installments on the following dates: (i) January 1, 2027, and (ii) January 1, 2028, and January 1, 2029.

F1 · shares: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares vest in three equal installments on the following dates: (i) January 1, 2027, and (ii) January 1, 2028, and January 1, 2029.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 22:02 UTC
HARRISON SHANE REVP & Chief Financial Officer
PurchaseCommon Stock 8,000 $12.27 $98,162.40
Disclosure

SEC source: 0001008886-26-000043 · form4.xml · nonDerivative · entry 1

HARRISON SHANE R · CIK 0001640089 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · IRA

Disclosed balance after: 8,000

F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $12.01 to $12.33, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range set forth in this footnote.

Read SEC document
January 22, 2026 Filed Feb 18, 2026 00:21 UTC GrantDirector Stock Option (Right to Buy) · Derivative 8,819 $0.00 Strike: $22.01 $0.00
Disclosure

SEC source: 0001008886-26-000041 · form4.xml · derivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,819

Underlying: Common Stock · 8,819 shares

Expires 2036-01-22

F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings since the 2025 Annual Meeting of Stockholders.

Read SEC document
January 22, 2026 Filed Feb 18, 2026 00:19 UTC GrantDirector Stock Option (Right to Buy) · Derivative 8,819 $0.00 Strike: $22.01 $0.00
Disclosure

SEC source: 0001008886-26-000040 · form4.xml · derivative · entry 1

Bhandari Parul · CIK 0001861355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,819

Underlying: Common Stock · 8,819 shares

Expires 2036-01-22

F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings since the 2025 Annual Meeting of Stockholders.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 22:39 UTC
Hays Michael D.Director · Chairman
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 9,145 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0001008886-26-000008 · form4.xml · derivative · entry 3

Hays Michael D. · CIK 0001053133 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,145 shares

Expires 2026-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2026 Filed Jan 7, 2026 22:39 UTC
Hays Michael D.Director · Chairman
Exercise / conversionCommon Stock 9,145 $15.23 $139,278.35
Disclosure

SEC source: 0001008886-26-000008 · form4.xml · nonDerivative · entry 1

Hays Michael D. · CIK 0001053133 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2026 Filed Jan 16, 2026 21:13 UTC
Burik DavidEVP, Strategic Insights
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-26-000012 · form4.xml · nonDerivative · entry 1

Burik David · CIK 0002105843 · EVP, Strategic Insights

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · kind: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029.

F1 · shares: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares will vest in three approximately equal installments on the following dates: (i) January 5, 2027, (ii) January 5, 2028, and (iii) January 5, 2029.

Read SEC document
December 29, 2025 Filed Jan 26, 2026 23:10 UTC
HARRISON SHANE REVP & Chief Financial Officer
Tax withholdingCommon Stock 21,271 $18.66 $396,916.86
Disclosure

SEC source: 0001008886-26-000015 · form4.xml · nonDerivative · entry 1

HARRISON SHANE R · CIK 0001640089 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,729

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:23 UTC
Hrdy HelenEVP & Chief Operating Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,346 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0001008886-25-000321 · form4.xml · derivative · entry 3

Hrdy Helen · CIK 0001833916 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,346 shares

Expires 2026-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:23 UTC
Hrdy HelenEVP & Chief Operating Officer
Tax withholdingCommon Stock 11,244 $17.64 $198,344.16
Disclosure

SEC source: 0001008886-25-000321 · form4.xml · nonDerivative · entry 2

Hrdy Helen · CIK 0001833916 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,518

Read SEC document
December 15, 2025 Filed Dec 17, 2025 23:23 UTC
Hrdy HelenEVP & Chief Operating Officer
Exercise / conversionCommon Stock 12,346 $15.23 $188,029.58
Disclosure

SEC source: 0001008886-25-000321 · form4.xml · nonDerivative · entry 1

Hrdy Helen · CIK 0001833916 · EVP & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 23:20 UTC GrantDirector Stock Option (Right to Buy) · Derivative 22,625 $0.00 Strike: $11.61 $0.00
Disclosure

SEC source: 0001008886-25-000279 · form4.xml · derivative · entry 1

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,625

Underlying: Common Stock · 22,625 shares

Expires 2035-10-17

F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings during 2025.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 23:18 UTC GrantDirector Stock Option (Right to Buy) · Derivative 22,625 $0.00 Strike: $11.61 $0.00
Disclosure

SEC source: 0001008886-25-000277 · form4.xml · derivative · entry 1

Wheeler Penny Ann · CIK 0001856610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,625

Underlying: Common Stock · 22,625 shares

Expires 2035-10-17

F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings during 2025.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 23:16 UTC GrantDirector Stock Option (Right to Buy) · Derivative 22,625 $0.00 Strike: $11.61 $0.00
Disclosure

SEC source: 0001008886-25-000275 · form4.xml · derivative · entry 1

Berwick Donald M · CIK 0001656313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,625

Underlying: Common Stock · 22,625 shares

Expires 2035-10-17

F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings during 2025.

Read SEC document
September 29, 2025 Filed Oct 1, 2025 22:54 UTC
HARRISON SHANE REVP & Chief Financial Officer
GrantCommon Stock 172,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000265 · form4.xml · nonDerivative · entry 1

HARRISON SHANE R · CIK 0001640089 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,000

F1 · kind: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares vest in four equal installments on the following dates: (i) December 28, 2025, (ii) September 29, 2026, (iii) September 29, 2027, and (iv) September 29, 2028.

F1 · shares: Represents restricted shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan. Subject to certain vesting, forfeiture, and termination provisions, the restricted shares vest in four equal installments on the following dates: (i) December 28, 2025, (ii) September 29, 2026, (iii) September 29, 2027, and (iv) September 29, 2028.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 20:40 UTC
Freeman Jordan NicoleChief Accounting Officer
PurchaseCommon Stock 771 $12.97 $9,999.87
Disclosure

SEC source: 0001008886-25-000239 · form4.xml · nonDerivative · entry 1

Freeman Jordan Nicole · CIK 0002066098 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 771

Read SEC document
June 01, 2025 Filed Jun 3, 2025 20:47 UTC
Green Trent SDirector · Chief Executive Officer
GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000176 · form4.xml · nonDerivative · entry 1

Green Trent S · CIK 0002058798 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

F1 · kind: Represents fully-vested shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

F1 · shares: Represents fully-vested shares of common stock issued under the National Research Corporation 2025 Omnibus Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

Read SEC document
May 12, 2025 Filed May 13, 2025 15:30 UTC PurchaseCommon Stock 2,500 $13.59 $33,973.75
Disclosure

SEC source: 0001008886-25-000118 · form4.xml · nonDerivative · entry 1

BEANS PATRICK E · CIK 0001247187 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,003

F1 · price: The price reflects a weighted average purchase price for multiple transactions ranging from $13.555 to $13.6445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a stockholder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
May 07, 2025 Filed May 9, 2025 21:11 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,917 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001008886-25-000116 · form4.xml · derivative · entry 1

Bhandari Parul · CIK 0001861355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,917

Underlying: Common Stock · 34,917 shares

Expires 2035-05-07

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
May 07, 2025 Filed May 9, 2025 21:09 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,917 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001008886-25-000115 · form4.xml · derivative · entry 1

Wheeler Penny Ann · CIK 0001856610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,917

Underlying: Common Stock · 34,917 shares

Expires 2035-05-07

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
May 07, 2025 Filed May 9, 2025 21:08 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,917 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001008886-25-000114 · form4.xml · derivative · entry 1

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,917

Underlying: Common Stock · 34,917 shares

Expires 2035-05-07

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
May 07, 2025 Filed May 9, 2025 21:07 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,917 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001008886-25-000113 · form4.xml · derivative · entry 1

Berwick Donald M · CIK 0001656313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,917

Underlying: Common Stock · 34,917 shares

Expires 2035-05-07

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
May 07, 2025 Filed May 9, 2025 21:05 UTC GrantDirector Stock Option (Right to Buy) · Derivative 34,917 $0.00 Strike: $13.09 $0.00
Disclosure

SEC source: 0001008886-25-000112 · form4.xml · derivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,917

Underlying: Common Stock · 34,917 shares

Expires 2035-05-07

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.

Read SEC document
April 07, 2025 Filed Apr 9, 2025 21:01 UTC
Monnich AndrewChief Corp. Development Off.
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000069 · form4.xml · nonDerivative · entry 1

Monnich Andrew · CIK 0002006660 · Chief Corp. Development Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · kind: Represents fully-vested shares of common stock issued under the National Research Corporation 2006 Equity Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

F1 · shares: Represents fully-vested shares of common stock issued under the National Research Corporation 2006 Equity Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

Read SEC document
April 07, 2025 Filed Apr 9, 2025 21:00 UTC
Hrdy HelenChief Operating Officer
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000068 · form4.xml · nonDerivative · entry 1

Hrdy Helen · CIK 0001833916 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,416

F1 · kind: Represents fully-vested shares of common stock issued under the National Research Corporation 2006 Equity Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

F1 · shares: Represents fully-vested shares of common stock issued under the National Research Corporation 2006 Equity Incentive Plan, which are subject to (i) certain transfer restrictions and (ii) repurchase by the issuer in certain circumstances.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 22:22 UTC
Hays Michael D.Director · CEO & President
GrantEmployee Stock Option (right to buy) · Derivative 11,021 $0.00 Strike: $17.34 $0.00
Disclosure

SEC source: 0001008886-25-000014 · form4.xml · derivative · entry 1

Hays Michael D. · CIK 0001053133 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,021

Underlying: Common Stock · 11,021 shares

Expires 2035-01-10

F1 · derivative.exercise_date: This option becomes fully exercisable on January 10, 2030.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:18 UTC
Hays Michael D.Director · CEO & President
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 10,014 $0.00 Strike: $13.17 $0.00
Disclosure

SEC source: 0001008886-25-000012 · form4.xml · derivative · entry 3

Hays Michael D. · CIK 0001053133 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,014 shares

Expires 2025-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:18 UTC
Hays Michael D.Director · CEO & President
Exercise / conversionCommon Stock 10,014 $13.17 $131,884.38
Disclosure

SEC source: 0001008886-25-000012 · form4.xml · nonDerivative · entry 1

Hays Michael D. · CIK 0001053133 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2024 Filed Apr 10, 2025 20:56 UTC GiftCommon Stock 4,755,317 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000088 · form4.xml · nonDerivative · entry 1

Amandla MK Trust · CIK 0001729470 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Amandla, LLC

Disclosed balance after: 0

F1 · shares: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC. The 4,755,317 shares held by Amandla, LLC as of December 31, 2024, reflects that 923,955 shares were transferred from Amandla II, LLC (then an indirect wholly owned subsidiary of Amandla MK Trust) to Amandla, LLC on April 5, 2024.

Read SEC document
December 31, 2024 Filed Apr 10, 2025 20:59 UTC GiftCommon Stock 4,755,317 $0.00 $0.00
Disclosure

SEC source: 0001008886-25-000090 · form4.xml · nonDerivative · entry 1

Common Property Trust · CIK 0001847052 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Amandla, LLC

Disclosed balance after: 4,755,317

F1 · shares: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:13 UTC GrantDirector Stock Option (Right to Buy) · Derivative 10,906 $0.00 Strike: $29.76 $0.00
Disclosure

SEC source: 0001008886-24-000150 · form4.xml · derivative · entry 1

Bhandari Parul · CIK 0001861355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,906

Underlying: Common Stock · 10,906 shares

Expires 2034-05-08

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:12 UTC GrantDirector Stock Option (Right to Buy) · Derivative 10,906 $0.00 Strike: $29.76 $0.00
Disclosure

SEC source: 0001008886-24-000149 · form4.xml · derivative · entry 1

Wheeler Penny Ann · CIK 0001856610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,906

Underlying: Common Stock · 10,906 shares

Expires 2034-05-08

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:10 UTC GrantDirector Stock Option (Right to Buy) · Derivative 10,906 $0.00 Strike: $29.76 $0.00
Disclosure

SEC source: 0001008886-24-000148 · form4.xml · derivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,906

Underlying: Common Stock · 10,906 shares

Expires 2034-05-08

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:08 UTC GrantDirector Stock Option (Right to Buy) · Derivative 10,906 $0.00 Strike: $29.76 $0.00
Disclosure

SEC source: 0001008886-24-000147 · form4.xml · derivative · entry 1

Berwick Donald M · CIK 0001656313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,906

Underlying: Common Stock · 10,906 shares

Expires 2034-05-08

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:06 UTC GrantDirector Stock Option (Right to Buy) · Derivative 10,906 $0.00 Strike: $29.76 $0.00
Disclosure

SEC source: 0001008886-24-000146 · form4.xml · derivative · entry 1

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,906

Underlying: Common Stock · 10,906 shares

Expires 2034-05-08

F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan.

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:07 UTC Exercise / conversionDirector Stock Option (Right to Buy) · Derivative 9,259 $0.00 Strike: $14.95 $0.00
Disclosure

SEC source: 0001008886-24-000100 · form4.xml · derivative · entry 3

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,259 shares

Expires 2024-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:07 UTC Tax withholdingCommon Stock 3,487 $39.70 $138,433.90
Disclosure

SEC source: 0001008886-24-000100 · form4.xml · nonDerivative · entry 2

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,666

Read SEC document
March 27, 2024 Filed Mar 29, 2024 21:07 UTC Exercise / conversionCommon Stock 9,259 $14.95 $138,422.05
Disclosure

SEC source: 0001008886-24-000100 · form4.xml · nonDerivative · entry 1

NUNNELLY JOHN N · CIK 0001248110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,153

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:27 UTC SaleCommon Stock 598,653 $40.54 $24,269,392.62
Disclosure

SEC source: 0001008886-24-000079 · form4.xml · nonDerivative · entry 1

Common Property Trust · CIK 0001847052 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Common Property Trust LLC

Disclosed balance after: 3,854,284

F1 · shares: Represents a private sale of shares.

Read SEC document
January 05, 2024 Filed Jan 8, 2024 22:14 UTC SaleCommon Stock 2,614 $40.20 $105,092.47
Disclosure

SEC source: 0001008886-24-000028 · form4.xml · nonDerivative · entry 2

Amandla MK Trust · CIK 0001729470 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Amandla LLC

Disclosed balance after: 3,831,362

F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.09 to $40.23, inclusive.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 22:14 UTC SaleCommon Stock 4,600 $41.22 $189,617.06
Disclosure

SEC source: 0001008886-24-000028 · form4.xml · nonDerivative · entry 1

Amandla MK Trust · CIK 0001729470 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Amandla LLC

Disclosed balance after: 3,833,976

F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $41.05 to $41.29, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 22:08 UTC SaleCommon Stock 120,139 $41.77 $5,018,758.67
Disclosure

SEC source: 0001008886-24-000023 · form4.xml · nonDerivative · entry 3

Amandla MK Trust · CIK 0001729470 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Amandla LLC

Disclosed balance after: 3,838,576

F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $41.535 to $42.11, inclusive.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:25 UTC SaleCommon Stock 364,625 $41.53 $15,142,876.25
Disclosure

SEC source: 0001008886-24-000026 · form4.xml · nonDerivative · entry 1

Common Property Trust · CIK 0001847052 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Common Property Trust LLC

Disclosed balance after: 4,452,937

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:10 UTC
Hays Michael D.Director · CEO & President
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,904 $0.00 Strike: $18.80 $0.00
Disclosure

SEC source: 0001008886-24-000024 · form4.xml · derivative · entry 4

Hays Michael D. · CIK 0001053133 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,904 shares

Expires 2024-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:10 UTC
Hays Michael D.Director · CEO & President
Tax withholdingCommon Stock 1,909 $39.56 $75,520.04
Disclosure

SEC source: 0001008886-24-000024 · form4.xml · nonDerivative · entry 2

Hays Michael D. · CIK 0001053133 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 995

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.